European Reference Network (ERN) ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Methodological detailsexpert task force statement, multidisciplinary Task Force, expert clinicians and ePAG Advocates
- Expert task force statement
- Multidisciplinary Task Force
- Expert clinicians and ePAG Advocates
Scope
As issued by the authors
Homogenous approach to treating immunocompromised patients with autoimmune rheumatic disease (ARDs) (focus on CTDs) affected by COVID-19 using antiviral therapies and anti-SARS-CoV-2 antibody products
Original publication
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products. Clin Exp Rheumatol. Published 2 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →